FDA warning letter
Issue date
13 Apr 2022
Issuing office
Center for Drug Evaluation and Research | CDER
Posted date
19 Apr 2022
Subject
Finished Pharmaceuticals/Unapproved New Drug/Misbranded
Products & Services
Drugs
Headquarters
Issue date
Issuing office
Posted date
Subject
Products & Services